| Ticker Symbol: | RODM |
|---|---|
| Exchange: | NASD |
| Contact Info: | |
| CEO/President: | |
| Industry: | Finance - Investment Brokers / Standard Industry Code: 6162 |
| Description: | Rodman & Renshaw is a full service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies, along with research and sales and trading services to institutional investor clients that focus on such companies. Through its AcumenBioFinTM division, Rodman is a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE and RD transaction markets. |
| Shares Outstanding: | 34,770 (000) | Market Value: | 58,640 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 12.51% | Number of Inst.Shareholders: | N/A% |
| Last Quarter Sales: | 29.53 ($Mil.) | Last Quarter Net Income: | 6.00 ($Mil.) |
| Last Quarter EPS: | 0.18 | P/E Ratio: | 10 |
| Most Recent Earnings: | Earnings Per Share: | 0.01 | |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| ML CO CMN STK | -70.20 | 26.11 | |
| MORGAN STANLEY | -57.30 | 27.10 | |
| GOLDMAN SACHS G | -41.40 | 135.50 | |
| E*TRADE FINL CO | -68.10 | 3.49 | |
| CHARLES SCHWAB | +12.20 | 23.57 |
